Literature DB >> 30464694

Changes in preoperative endoscopic and percutaneous bile drainage in patients with periampullary cancer undergoing pancreaticoduodenectomy in Ontario: effect on clinical practice of a randomized trial.

D J Kagedan1, J D Mosko2,3, M E Dixon1, P J Karanicolas1,3,4, A C Wei1,3,5,6, N Goyert4, Q Li7, N Mittmann8, N G Coburn1,3,4,5.   

Abstract

Background: In 2010, a multicentre randomized controlled trial reported increased postoperative complications in pancreaticoduodenectomy (pde) patients undergoing preoperative biliary decompression (pbd). We evaluated the effect of that publication on rates of pbd at the population level.
Methods: This retrospective observational cohort study identified patients undergoing pde for malignancy, 2005-2013, linking them with administrative health care databases covering medical services for a population of 13.5 million. Patients undergoing pbd within 6 weeks before their surgery were identified using physician billing codes and were divided into those undergoing pde before and after article publication, with a 6-month washout period. Chi-square tests were used to compare rates of pbd.
Results: Of 1997 pde patients identified, 963 underwent surgery before article publication, and 911, after (123 during the washout period). The rate of pbd was 47.5% before publication, and 41.6% after (p = 0.01). The lowest pbd rates occurred immediately after publication, in 2010 and 2011. Similar results were observed when the cohort was restricted to patients seen preoperatively by a gastroenterologist (n = 1412). Conclusions: Rates of pbd have declined a small, but significant, amount after randomized trial publication. Persistence of pbd might relate to suboptimal knowledge translation, the role of pbd in diagnosis of periampullary malignancy, and treatment of complications (cholangitis, severe hyperbilirubinemia) or anticipation of delay from diagnosis to surgery. The nadir in pbd rates after article publication and the subsequent rise suggest an element of transience in the effect of article publication on clinical practice. Further investigation into the reasons for persistent pbd is needed.

Entities:  

Keywords:  Pancreatic neoplasia; outcomes; periampullary tumours; resection

Mesh:

Year:  2018        PMID: 30464694      PMCID: PMC6209556          DOI: 10.3747/co.25.4007

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  31 in total

1.  Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital.

Authors:  Klaus Sahora; Vicente Morales-Oyarvide; Cristina Ferrone; Zhi Ven Fong; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo
Journal:  J Hepatobiliary Pancreat Sci       Date:  2016-02-23       Impact factor: 7.027

2.  Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience.

Authors:  F Francesco di Mola; Francesca Tavano; R Rita Rago; Antonio De Bonis; M Rosa Valvano; Angelo Andriulli; Pierluigi di Sebastiano
Journal:  Langenbecks Arch Surg       Date:  2014-03-29       Impact factor: 3.445

Review 3.  The current status of preoperative biliary drainage for patients who receive pancreaticoduodenectomy for periampullary carcinoma: a comprehensive review.

Authors:  Eric C H Lai; Stephanie H Y Lau; Wan Yee Lau
Journal:  Surgeon       Date:  2014-03-17       Impact factor: 2.392

4.  Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage.

Authors:  Tobin J Strom; Jason B Klapman; Gregory M Springett; Kenneth L Meredith; Sarah E Hoffe; Junsung Choi; Pamela Hodul; Mokenge P Malafa; Ravi Shridhar
Journal:  Surg Endosc       Date:  2015-01-29       Impact factor: 4.584

5.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

6.  Obstructive jaundice and wound healing.

Authors:  L Grande; J C Garcia-Valdecasas; J Fuster; J Visa; C Pera
Journal:  Br J Surg       Date:  1990-04       Impact factor: 6.939

7.  Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

Authors:  T A Sohn; C J Yeo; J L Cameron; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

8.  Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study.

Authors:  Kenichiro Uemura; Yoshiaki Murakami; Sohei Satoi; Masayuki Sho; Fuyuhiko Motoi; Manabu Kawai; Ippei Matsumoto; Goro Honda; Masanao Kurata; Hiroaki Yanagimoto; Satoshi Nishiwada; Takumi Fukumoto; Michiakil Unno; Hiroki Yamaue
Journal:  Ann Surg Oncol       Date:  2015-05-27       Impact factor: 5.344

9.  Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records.

Authors:  S E Schultz; D M Rothwell; Z Chen; K Tu
Journal:  Chronic Dis Inj Can       Date:  2013-06

Review 10.  Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review.

Authors:  Harsha Moole; Matthew Bechtold; Srinivas R Puli
Journal:  World J Surg Oncol       Date:  2016-07-11       Impact factor: 2.754

View more
  2 in total

1.  Association of the rate of bilirubin decrease with major morbidity in patients undergoing preoperative biliary drainage before pancreaticoduodenectomy.

Authors:  Narongsak Rungsakulkij; Varinthip Thongchai; Wikran Suragul; Watoo Vassanasiri; Pongsatorn Tangtawee; Paramin Muangkaew; Somkit Mingphruedhi; Suraida Aeesoa
Journal:  SAGE Open Med       Date:  2021-08-16

2.  Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel.

Authors:  Xiaocheng Li; Zhiyang Jiang; Yongjuan Wu; Wei Gong; Xiaofeng Liao; Xiaogang Li
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.